NCT06785051 AI-based Physiotherapy for Oral Cancer Patients
| NCT ID | NCT06785051 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National Taiwan University Hospital |
| Condition | Oral Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-02-19 |
| Primary Completion | 2027-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2025-02-19 with a primary completion date of 2027-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study examines the effects of AI-based physiotherapy on oral function, shoulder function, whole-body physical function, and quality of life in oral cancer patients. One hundred patients will be recruited before surgery, chemotherapy, or radiotherapy and randomly assigned to an experimental group receiving 12 weeks of AI-guided physiotherapy or a control group receiving usual care. Both groups will perform jaw, neck, and shoulder exercises, with the experimental group using a mobile app to monitor progress. Assessments at baseline, pre-intervention, and 3 months post-intervention will measure maximal in the maximum interincisal opening (MIO), joint range of motion (ROM), pain, endurance (e.g., 6-minute walk test), upper extremity function, and quality of life.
Eligibility Criteria
Inclusion Criteria: * Newly diagnosed oral cancer patients who are scheduled to receive cancer-related treatments (e.g., oral cancer surgery, radiotherapy, chemotherapy, or chemoradiotherapy). * Age between 20 and 65 years. Exclusion Criteria: * Could not communicate. * Had any disorder that could influence movement performance.
Contact & Investigator
Yueh-Hsia Chen, PhD
PRINCIPAL INVESTIGATOR
National Taiwan University, College of Medicine
Frequently Asked Questions
Who can join the NCT06785051 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 65 Years, studying Oral Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06785051 currently recruiting?
Yes, NCT06785051 is actively recruiting participants. Contact the research team at yuehhsiachen@ntu.edu.tw for enrollment information.
Where is the NCT06785051 trial being conducted?
This trial is being conducted at Taipei, Taiwan, Taipei, Taiwan.
Who is sponsoring the NCT06785051 clinical trial?
NCT06785051 is sponsored by National Taiwan University Hospital. The principal investigator is Yueh-Hsia Chen, PhD at National Taiwan University, College of Medicine. The trial plans to enroll 100 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.